These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12631632)

  • 21. [Intraarterial infusion combination therapy with LV and 5-FU in hepatic metastases from colorectal cancer].
    Seshimo A; Aratake T; Matsumoto M; Kawase A; Kirita T; Kameoka S; Hamano K
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2162-4. PubMed ID: 7944429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
    Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
    Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical study of hepatic arterial infusion chemotherapy with 5-FU and leucovorin for liver metastases].
    Ichihara T; Tenma K; Itoh M; Hibino M; Kikuchi I; Sasaki Y; Hosono Y; Nakamura M
    Gan To Kagaku Ryoho; 2003 Aug; 30(8):1143-5. PubMed ID: 12938270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas.
    Galanis E; Okuno SH; Nascimento AG; Lewis BD; Lee RA; Oliveira AM; Sloan JA; Atherton P; Edmonson JH; Erlichman C; Randlev B; Wang Q; Freeman S; Rubin J
    Gene Ther; 2005 Mar; 12(5):437-45. PubMed ID: 15647767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.
    Tanaka K; Yabushita Y; Nakagawa K; Kumamoto T; Matsuo K; Taguri M; Endo I
    Eur J Surg Oncol; 2013 Dec; 39(12):1364-70. PubMed ID: 24183169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: a phase II trial using intermittent percutaneous hepatic arterial access.
    Copur MS; Capadano M; Lynch J; Goertzen T; McCowan T; Brand R; Tempero M
    J Clin Oncol; 2001 May; 19(9):2404-12. PubMed ID: 11331319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver-directed viral therapy for cancer p53-targeted adenoviruses and beyond.
    Warren RS; Kirn DH
    Surg Oncol Clin N Am; 2002 Jul; 11(3):571-88, vi. PubMed ID: 12487057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen).
    Lorenz M; Müller HH; Schramm H; Gassel HJ; Rau HG; Ridwelski K; Hauss J; Stieger R; Jauch KW; Bechstein WO; Encke A
    Ann Surg; 1998 Dec; 228(6):756-62. PubMed ID: 9860474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy for unresectable tumors of the liver].
    Hashimoto N; Kohno H; Kubota H; Hayashi T; Uchida M; Yamanoi A; Ono T; Nagasue N
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1586-9. PubMed ID: 7574766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI.
    Arai Y; Ohtsu A; Sato Y; Aramaki T; Kato K; Hamada M; Muro K; Yamada Y; Inaba Y; Shimada Y; Boku N; Takeuchi Y; Morita S; Satake M
    J Vasc Interv Radiol; 2012 Oct; 23(10):1261-7. PubMed ID: 22922040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is repeated treatment with a 5-fluorouracil-based regimen useful in colorectal cancer?
    Goldberg RM
    Semin Oncol; 1998 Oct; 25(5 Suppl 11):21-8. PubMed ID: 9786313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver.
    Au T; Thorne S; Korn WM; Sze D; Kirn D; Reid TR
    Cancer Gene Ther; 2007 Feb; 14(2):139-50. PubMed ID: 17139321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
    In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
    Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I/II study of irinotecan, UFT and leucovorin with hepatic arterial infusion using 5-FU in colorectal cancer patients with unresectable liver metastases.
    Yamaguchi T; Matsumoto H; Yasutome M; Mori T; Takahashi K
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):629-35. PubMed ID: 20495917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V; Malka D; Elias D; Castaing M; De Baere T; Goere D; Dromain C; Pocard M; Ducreux M
    Ann Surg Oncol; 2008 Jan; 15(1):219-26. PubMed ID: 17896145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.
    Makower D; Rozenblit A; Kaufman H; Edelman M; Lane ME; Zwiebel J; Haynes H; Wadler S
    Clin Cancer Res; 2003 Feb; 9(2):693-702. PubMed ID: 12576437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combined treatment of inoperable liver metastases from colorectal cancer].
    Milandri C; Calzolari F; Giampalma E; Vagliasindi A; Bertagni A; Ridolfi L; Passardi A; Ridolfi R; Golfieri R; Verdecchia GM
    Tumori; 2003; 89(4 Suppl):112-4. PubMed ID: 12903565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.